Disseminated Intravascular Coagulation-like Reaction after Rituximab Infusion in a Patient with Nephrotic Syndrome-Reference-Cited by-同舟云学术

Disseminated Intravascular Coagulation-like Reaction after Rituximab Infusion in a Patient with Nephrotic Syndrome

Published:2019-07-15 Issue:14 Volume:58 Page:2057-2061
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Nishiwaki Hiroki¹,Oikawa Megumi¹,Kajitani Hideto¹,Komukai Daisuke¹²,Inoue Yoshihiko¹,Koiwa Fumihiko¹

Affiliation:

1. Division of Nephrology, Department of Medicine, Showa University Fujigaoka Hospital, Japan

2. Division of Nephrology, Kawasaki-Saiwai Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/58/14/58_2236-18/_pdf

Reference31 articles.

1. 1. Engelhard M. Anti-CD20 antibody treatment of non-Hodgkin lymphomas. Clin Immunol 172: 101-104, 2016.

2. 2. KDIGO. clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2: 1-274, 2012.

3. 3. Prytula A, Lijima K, Kamei K, et al. Rituximab in refractory nephrotic syndrome. Pediatr Nephrol 25: 461-468, 2010.

4. 4. Ravani P, Magnasco A, Edefonti A, et al. Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial. Clin J Am Soc Nephrol 6: 1308-1315, 2011.

5. 5. Beco A, Castro-Ferreira I, Coentrao L, et al. Rituximab for steroid dependent nephrotic syndrome. Clin Nephrol 74: 308-310, 2010.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein and lymphatic loss conditions;Stiehm's Immune Deficiencies;2020

2. Successful rechallenge of rituximab following severe rituximab-induced acute thrombocytopenia in a patient with splenic marginal zone lymphoma;Journal of Oncology Pharmacy Practice;2019-11-25

3. Rituximab;Reactions Weekly;2019-09